Cargando…
Production, quality control, and bio-distribution studies of (159)Gd-EDTMP as a palliative agent for bone pain
INTRODUCTION: Particle-emitting, bone-seeking radiopharmaceuticals have attracted the attention of the nuclear medicine community over the last three decades for the treatment of the pain of osteoblastic metastases. The objectives of this research were to produce quality-controlled (159)Gd-EDTMP in...
Autores principales: | Arani*, Simindokht Shirvani, Ghasemi, Somaye, Samani, Ali Bahrami, Zafarghandi, Mojtaba Shamsaei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Electronic physician
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455298/ https://www.ncbi.nlm.nih.gov/pubmed/26052408 http://dx.doi.org/10.14661/2015.977-984 |
Ejemplares similares
-
Production and quality control (177)Lu (NCA)—DOTMP as a potential agent for bone pain palliation
por: Salek, Nafise, et al.
Publicado: (2016) -
Production, Quality Control and Pharmacokinetic Studies of (177)Lu-EDTMP for Human Bone Pain Palliation Therapy Trials
por: Bahrami-Samani, Ali, et al.
Publicado: (2012) -
Production, Quality Control and Pharmacokinetic Studies of (166)Ho-EDTMP for Therapeutic Applications
por: Bahrami-Samani, Ali, et al.
Publicado: (2010) -
Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis
por: Ayati, Narjess, et al.
Publicado: (2013) -
Synthesis and Ready to Use Kit Formulation of EDTMP for the Preparation of 177Lu-EDTMP as a Bone Palliation Radiopharmaceutical
por: Mercanoglu, Guldem, et al.
Publicado: (2023)